Thursday 29 November 2018

Montelukast Sodium Global Industry 2018 Sales, Supply, Size, and Consumption Forecasts to 2023

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
Scope of the Report:This report focuses on the Montelukast Sodium in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Montelukast sodium can be classified as two types, such as montelukast sodium smorphous and montelukast sodium crystalline. It can be widely used in pharmaceutical industry. Survey results showed that 72.28% of the montelukast sodium market is tablets, 21.44% is chewable tablet and 6.28% is oral solution, this industry will need more montelukast sodium. So, montelukast sodium has a huge market potential in the future.

Montelukast Sodium Global Industry 2018 Sales, Supply, Size, and Consumption Forecasts to 2023       

The worldwide market for Montelukast Sodium is expected to grow at a CAGR of roughly 12.1% over the next five years, will reach 390 million US$ in 2023, from 190 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Groups
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Market Segment by Applications, can be divided into
Tablets
Chewable Tablet
Oral Solution


Table of Contents -Major Key Points
1 Market Overview1.1 Montelukast Sodium Introduction
1.2 Market Analysis by Type
1.2.1 Montelukast Sodium Amorphous
1.2.2 Montelukast Sodium Crystalline
1.3 Market Analysis by Applications
1.3.1 Tablets
1.3.2 Chewable Tablet
1.3.3 Oral Solution
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles2.1 Morepen Laboratories
2.1.1 Business Overview
2.1.1.1 Morepen Laboratories Description
2.1.1.2 Morepen Laboratories Headquarter, Main Business and Finance Overview
2.1.2 Morepen Laboratories Montelukast Sodium Product Introduction
2.1.2.1 Montelukast Sodium Production Bases, Sales Regions and Major Competitors
2.1.2.2 Montelukast Sodium Product Information
2.1.3 Morepen Laboratories Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Morepen Laboratories Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Morepen Laboratories Montelukast Sodium Market Share in 2017
2.2 Mylan
2.2.1 Business Overview
2.2.1.1 Mylan Description
2.2.1.2 Mylan Headquarter, Main Business and Finance Overview
2.2.2 Mylan Montelukast Sodium Product Introduction
2.2.2.1 Montelukast Sodium Production Bases, Sales Regions and Major Competitors
2.2.2.2 Montelukast Sodium Product Information
2.2.3 Mylan Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Mylan Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Mylan Montelukast Sodium Market Share in 2017
2.3 TAPI
2.3.1 Business Overview
2.3.1.1 TAPI Description
2.3.1.2 TAPI Headquarter, Main Business and Finance Overview
2.3.2 TAPI Montelukast Sodium Product Introduction
2.3.2.1 Montelukast Sodium Production Bases, Sales Regions and Major Competitors
2.3.2.2 Montelukast Sodium Product Information
2.3.3 TAPI Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 TAPI Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global TAPI Montelukast Sodium Market Share in 2017
2.4 MSN Laboratories
2.4.1 Business Overview
2.4.1.1 MSN Laboratories Description
2.4.1.2 MSN Laboratories Headquarter, Main Business and Finance Overview
2.4.2 MSN Laboratories Montelukast Sodium Product Introduction
2.4.2.1 Montelukast Sodium Production Bases, Sales Regions and Major Competitors
2.4.2.2 Montelukast Sodium Product Information
2.4.3 MSN Laboratories Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 MSN Laboratories Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global MSN Laboratories Montelukast Sodium Market Share in 2017
2.5 Ultratech India
2.5.1 Business Overview
2.5.1.1 Ultratech India Description
2.5.1.2 Ultratech India Headquarter, Main Business and Finance Overview
2.5.2 Ultratech India Montelukast Sodium Product Introduction
2.5.2.1 Montelukast Sodium Production Bases, Sales Regions and Major Competitors
2.5.2.2 Montelukast Sodium Product Information
2.5.3 Ultratech India Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Ultratech India Montelukast Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Ultratech India Montelukast Sodium Market Share in 2017
 ……..CONTINUED
Contact Information:
NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

http://www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)            
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)